Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020

BUY
$54.41 - $68.2 $508,842 - $637,806
9,352 Added 97.81%
18,913 $1.04 Million
Q3 2020

Oct 26, 2020

SELL
$54.41 - $68.2 $499,919 - $626,621
-9,188 Reduced 49.01%
9,561 $721,000
Q2 2020

Jul 20, 2020

BUY
$61.66 - $70.16 $305,155 - $347,221
4,949 Added 35.86%
18,749 $1.25 Million
Q2 2020

Jul 20, 2020

SELL
$61.66 - $70.16 $271,242 - $308,633
-4,399 Reduced 24.17%
13,800 $1.25 Million
Q1 2020

Apr 16, 2020

BUY
$59.35 - $88.73 $505,840 - $756,245
8,523 Added 88.08%
18,199 $1.11 Million
Q4 2019

Jan 27, 2020

BUY
$74.18 - $97.92 $8,530 - $11,260
115 Added 1.2%
9,676 $851,000
Q2 2019

Jul 09, 2019

BUY
$83.92 - $108.88 $4,196 - $5,444
50 Added 0.53%
9,561 $817,000
Q1 2019

May 10, 2019

SELL
$85.97 - $108.09 $366,490 - $460,787
-4,263 Reduced 30.95%
9,511 $1.03 Million
Q2 2018

Jul 09, 2018

BUY
$97.62 - $120.59 $416,154 - $514,075
4,263 Added 44.82%
13,774 $1.59 Million
Q1 2018

May 10, 2019

SELL
$95.91 - $107.26 $1.01 Million - $1.13 Million
-10,523 Reduced 52.53%
9,511 $1.03 Million
Q1 2018

Apr 25, 2018

BUY
$95.91 - $107.26 $955,839 - $1.07 Million
9,966 Added 98.99%
20,034 $1.98 Million
Q4 2017

Feb 01, 2018

SELL
$104.5 - $126.38 $1.1 Million - $1.33 Million
-10,521 Reduced 51.1%
10,068 $1.05 Million
Q3 2017

Oct 31, 2017

BUY
$97.26 - $116.2 $997,595 - $1.19 Million
10,257 Added 99.27%
20,589 $2.32 Million
Q2 2017

Aug 10, 2017

BUY
N/A
10,332
10,332 $1.16 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.